⌘K

Login Start Free

Home/Filings/4/0001062993-23-007225

4//SEC Filing

Vance Terry 4

Accession 0001062993-23-007225

CIK 0001177648other

View on SEC.gov Company Profile

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 6:46 PM ET

Size

6.4 KB

Accession

0001062993-23-007225

Insider Transaction Report

Form 4

Period: 2023-03-16

ENANTA PHARMACEUTICALS INCENTA

Director

Transactions

Exercise/Conversion
Common Stock
2023-03-16$14.00/sh+5,800$81,200→ 21,095 total
Exercise/Conversion
Stock Option (right to buy)
2023-03-16−5,800→ 0 total
Exercise: $14.00Exp: 2023-03-20→ Common Stock (5,800 underlying)

Footnotes (1)

[F1]100% of the shares subject to the option are fully vested and exercisable.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

ENANTA PHARMACEUTICALS INC

CIK 0001177648

Entity typeother

Related Parties

1

filerCIK 0001572282

Filing Metadata

Form type: 4
Filed: Mar 16, 8:00 PM ET
Accepted: Mar 17, 6:46 PM ET
Size: 6.4 KB

View on SEC.gov